Tempus ECG-AF vs syngo Dynamics
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary objective is to proactively identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months, utilizing AI-driven analysis of 12-lead ECG recordings. This tool is ideal for integrating a predictive risk assessment into your clinical workflow to facilitate earlier identification and targeted follow-up for at-risk individuals.
View Tempus ECG-AF →Choose syngo Dynamics if…
Choose syngo Dynamics if your healthcare facility requires a comprehensive, enterprise-level solution for the efficient review, analysis, and structured reporting of cardiovascular images and data from multiple modalities. This tool is best suited for optimizing the management of a wide range of cardiac imaging studies, ensuring consistent reporting, and providing widespread, secure access to diagnostic information across your system.
View syngo Dynamics →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | syngo Dynamics |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
syngo Dynamicssyngo Dynamics offers a comprehensive user interface with HTML5-enabled remote access, intuitive tools for reading and reporting, and positive user feedback on its usability. In contrast, Tempus ECG-AF operates primarily as a backend algorithm without a dedicated user interface, integrating with existing systems for data input and output.
Clinical Value
Tempus ECG-AFTempus ECG-AF provides a direct, predictive clinical value by identifying patients at increased risk of developing Atrial Fibrillation (AF) within 12 months, enabling earlier intervention. While syngo Dynamics enhances the efficiency of cardiovascular imaging and reporting, its value is primarily in workflow optimization rather than a novel predictive diagnostic insight.
Pricing & Value
Tempus ECG-AFTempus ECG-AF offers a clear value proposition with established CMS reimbursement codes (CPT 0764T and CPT 0765T) and a specific Medicare rate, providing financial predictability for healthcare providers. syngo Dynamics requires direct contact for pricing and does not publicly disclose specific reimbursement pathways, making its financial value less transparent.
Enterprise Readiness
syngo Dynamicssyngo Dynamics is explicitly designed as a comprehensive enterprise solution with extensive integration capabilities across various hospital systems (EHR, HIS, CVIS, DICOM, HL-7) and flexible deployment options. While Tempus ECG-AF integrates with existing ECG systems, syngo Dynamics demonstrates a broader and more robust enterprise-level readiness.
Innovation
Tempus ECG-AFTempus ECG-AF represents a clear innovation with its FDA-cleared AI algorithm that provides a novel predictive insight into future AF risk from standard ECGs, trained on a large dataset of over 1.5 million ECGs. syngo Dynamics, while a sophisticated and comprehensive system, focuses more on optimizing existing cardiovascular imaging and reporting workflows rather than introducing a new AI-driven diagnostic breakthrough.
Support & Docs
syngo Dynamicssyngo Dynamics offers a more comprehensive support ecosystem, including dedicated customer training, online courses, a user community, and a clear mechanism for submitting support requests through 'teamplay Fleet'. It also explicitly states having a comprehensive set of documentation. Tempus ECG-AF provides general contact for support but lacks the detailed, multi-faceted support and documentation infrastructure described for syngo Dynamics.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | syngo Dynamics |
|---|---|---|
| Product Name | Tempus ECG-AF | syngo Dynamics |
| Company | Tempus AI, Inc. | Siemens Healthineers |
| Primary Purpose | AI-based algorithm for 12-lead ECG analysis to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. | Comprehensive cardiovascular imaging and reporting solution, enabling efficient review, analysis, and structured reporting of cardiac images and data across multiple modalities. |
| Target User/Application Focus | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for earlier identification of AF risk. | Comprehensive enterprise cardiovascular imaging & reporting. |
| Core Technology/Methodology | AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs. | Multimodality diagnostic image review and processing, structured reporting. |
| Supported Data/Integration | Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. | Integration with Sensis XP, Soarian Cardiology, HIS, CVIS, EMR; Support for DICOM and HL-7 via interface engines. |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and syngo Dynamics.